GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » EV-to-FCF

Auro Laboratories (BOM:530233) EV-to-FCF : (As of Apr. 13, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Auro Laboratories's Enterprise Value is ₹1,782.3 Mil. Auro Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.0 Mil. Therefore, Auro Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Auro Laboratories's EV-to-FCF or its related term are showing as below:

BOM:530233' s EV-to-FCF Range Over the Past 10 Years
Min: -10.59   Med: 0   Max: 0
Current: -10.59

BOM:530233's EV-to-FCF is ranked worse than
100% of 547 companies
in the Drug Manufacturers industry
Industry Median: 22.92 vs BOM:530233: -10.59

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-13), Auro Laboratories's stock price is ₹245.05. Auro Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹5.680. Therefore, Auro Laboratories's PE Ratio (TTM) for today is 43.14.


Auro Laboratories EV-to-FCF Historical Data

The historical data trend for Auro Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories EV-to-FCF Chart

Auro Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.35 3.21 -5.76 -45.18 -7.44

Auro Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -7.44 - - -

Competitive Comparison of Auro Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Auro Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Auro Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auro Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Auro Laboratories's EV-to-FCF falls into.


;
;

Auro Laboratories EV-to-FCF Calculation

Auro Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1782.272/0
=

Auro Laboratories's current Enterprise Value is ₹1,782.3 Mil.
Auro Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Auro Laboratories  (BOM:530233) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Auro Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=245.05/5.680
=43.14

Auro Laboratories's share price for today is ₹245.05.
Auro Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.680.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Auro Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Auro Laboratories Business Description

Traded in Other Exchanges
N/A
Address
S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines